Latixon-CV 625 Tablet
Latixon-CV 625 Tablet
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Gefrin CV Tablet
Goodman Gilman's Life Sciences Private Limited
Clavulanic Acid 125mg
Pack Size
strip of 6 tablets
Price
Save ₹255
that's 49% off!
About This Medicine
Product description & overview
Latixon-CV 625 Tablet: Combats Resistant Bacteria
Latixon-CV 625 Tablet is a powerful combination of Cefuroxime (500mg) and Clavulanic Acid (125mg). This potent antibiotic effectively combats bacterial infections by targeting resistant strains.
Key Features:
* Broad-spectrum activity: Effective against various bacteria including those commonly associated with respiratory tract, skin, urinary tract, and ear infections.
* Antibacterial Mechanism: Cefuroxime inhibits cell wall formation in bacteria while Clavulanic Acid prevents the development of resistance to Cefuroxime.
* Precise Dosage: Latixon-CV 625 Tablet ensures precise dosing for optimal efficacy and safety.
Suitable For:
Adults with infections like bronchitis, pneumonia, sinusitis, otitis media, urinary tract infections (UTI), and skin infections.
Note: Consult your healthcare professional before taking this medication. Latixon-CV 625 Tablet may interact with certain medications and should be used under medical supervision. Always follow instructions on the label or provided by your healthcare provider.
Active composition
Clavulanic Acid 125 mg
+1 more active ingredient
All Active Ingredients
Cefuroxime
Cefuroxime binds to penicillin-binding proteins, inhibiting peptidoglycan synthesis and compromising bacterial cell wall integrity.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Consuming alcohol with Latixon-CV 625 Tablet does not cause any harmful side effects.
High Risk
Pregnancy
Latixon-CV 625 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Not relevant, as Latixon-CV 625 Tablet is intended for use in hospitalised patients.
Exercise Caution
Liver
There is limited information available on the use of Latixon-CV 625 Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
Breastfeeding
Latixon-CV 625 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Consult Doctor
Kidney
There is limited information available on the use of Latixon-CV 625 Tablet in patients with kidney disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Latixon-CV 625 Tablet